Skip to content

Healthcare-Reality in Urological Oncology: Determining the actual implementation of decisions made by the Urological Tumor Board and identifying reasons for inadequate therapy implementation

Healthcare-Reality in Urological Oncology: Determining the actual implementation of decisions made by the Urological Tumor Board and identifying reasons for inadequate therapy implementation - UroTuboVersorgungsforschung

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00036586
Enrollment
200
Registered
2025-05-08
Start date
2025-04-08
Completion date
Unknown
Last updated
2025-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C61

Interventions

Group 1: Questioning of patients with Urological Cancer Diseases (renal cell carcinoma, urothelial carcinoma, testicular cancer, and prostate cancer) three month after they received or been recommende

Sponsors

Klink und Poliklinik für Urologie und Kinderurologie
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Inclusion criteria: o Consent obtained (consent form) o Older than 18 years o Urological cancer (renal cell carcinoma, urothelial carcinoma, testicular cancer, and prostate cancer)

Exclusion criteria

Exclusion criteria: Exclusion criterion: o Non-consent to the consent form

Design outcomes

Primary

MeasureTime frame
How many tumor board decisions for each entity are implemented within three months?

Secondary

MeasureTime frame
Was the therapy initiated according to the tumor board decisions? Why are the decided therapies not implemented within three months? How has the quality of life of the patients changed after the tumor board decision?

Countries

Germany

Contacts

Public ContactMaximilian PJK Brandt

Klinik und Poliklinik für Urologie und Kinderurologie Universitätsmedizin der Johannes Gutenberg-Universität Mainz

maximilian.brandt@unimedizin-mainz.de06131-172303

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026